SGMO
Sangamo Therapeutics·NASDAQ
--
--(--)
--
--(--)
9.56 / 10
Outperform
Analyst sentiment is overwhelmingly bullish: a single Strong Buy recommendation with 100% historical win rate. Fund‑flow rating is good (7.59/10), showing positive medium and large‑cap inflows despite overall negative trend. Combined, sentiment supports a positive outlook.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-10
InstitutionHC Wainwright & Co.
Times predicted2
Historical Win Rate100.0%
What is the analyst consensus for SGMO?
- SGMO holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 9.56/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
